(Q51961784)

19 April 2018

title

Immunocytochemical identification of carcinomas of unknown primary in serous effusions. (English)

1 reference

19 April 2018

author name string

Natalia Pomjanski

1

1 reference

19 April 2018

Hans Juergen Grote

2

1 reference

19 April 2018

Peyrüze Doganay

3

1 reference

19 April 2018

Viola Schmiemann

4

1 reference

19 April 2018

Birgit Buckstegge

5

1 reference

19 April 2018

Alfred Böcking

6

1 reference

19 April 2018

publication date

1 November 2005

1 reference

19 April 2018

published in

Diagnostic Cytopathology

1 reference

19 April 2018

volume

33

1 reference

19 April 2018

issue

5

1 reference

19 April 2018

page(s)

309-315

1 reference

19 April 2018

Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids

cites work

1 reference

Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears.

21 January 2018

1 reference

Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases

21 January 2018

1 reference

Diagnostic and therapeutic management of cancer of an unknown primary

21 January 2018

1 reference

7 January 2021

Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.

1 reference

7 January 2021

Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases

1 reference

7 January 2021

Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer

1 reference

7 January 2021

Unknown primary tumours

1 reference

7 January 2021

Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases

1 reference

7 January 2021

CDX-2 Homeobox Gene Expression Is a Reliable Marker of Colorectal Adenocarcinoma Metastases to the Lungs

1 reference

7 January 2021

Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor

1 reference

7 January 2021

Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens

1 reference

7 January 2021

Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14.

1 reference

7 January 2021

Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma

1 reference

7 January 2021

Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma

1 reference

7 January 2021

Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology

1 reference

7 January 2021

Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.

1 reference

7 January 2021

Thyroid transcription factor-1.

1 reference

7 January 2021

Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

1 reference

7 January 2021

Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?

1 reference

7 January 2021

Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.

1 reference

7 January 2021

The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin

1 reference

7 January 2021

The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary

1 reference

7 January 2021

OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma

1 reference

7 January 2021

Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.20393

1 reference

19 April 2018

1 reference

19 April 2018